¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"sensitized hemagglutination"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitized cell
    ¹Î°¨È­¼¼Æ÷
  • sensitized corpuscle
    ¹Î°¨È­ÀûÇ÷±¸
  • sensitized lymphocyte
    ¹Î°¨È­¸²ÇÁ±¸
  • hemagglutination
    ÀûÇ÷±¸ÀÀÁý, Ç÷±¸ÀÀÁý
  • hemagglutination assay
    Ç÷±¸ÀÀÁý°Ë»ç
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦°Ë»ç
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • immune adherence hemagglutination
    ¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
  • indirect hemagglutination
    °£Á¢ÀûÇ÷±¸ÀÀÁý
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • viral hemagglutination
    ¹ÙÀÌ·¯½ºÀûÇ÷±¸ÀÀÁý
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hemagglutination
    ÀûÇ÷±¸ÀÀÁý
  • hemagglutination test
    Ç÷±¸ÀÀÁý½ÃÇè, Ç÷±¸ÀÀÁý°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitized hemagglutination
    ¹Î°¨ÀûÇ÷±¸ÀÀÁý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitized antigen
    ¹Î°¨Ç׿ø
  • sensitized cell
    ¹Î°¨¼¼Æ÷
  • sensitized corpuscle
    ¹Î°¨ÀûÇ÷±¸
  • sensitized lymphocyte
    ¹Î°¨¸²ÇÁ±¸
  • hemagglutination assay
    Ç÷±¸ÀÀÁýÃøÁ¤(¹ý)
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü
  • hemagglutination
    ÀûÇ÷±¸ÀÀÁý
  • hemagglutination test
    Ç÷±¸ÀÀÁý½ÃÇè, Ç÷±¸ÀÀÁý°Ë»ç
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦°Ë»ç
  • hemagglutination-inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ
  • immune adherence hemagglutination
    ¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
  • indirect hemagglutination
    °£Á¢ÀûÇ÷±¸ÀÀÁý¹ý
  • passive hemagglutination
    ¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • reversed passive hemagglutination
    ¿ª¼öµ¿ÀûÇ÷±¸ÀÀÁý
  • spike hemagglutination
    ÀûÇ÷±¸ÀÀÁýµ¹±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • HA= hemagglutination
    ÀûÇ÷±¸ÀÀÁý(¹ÝÀÀ).
  • HIT= hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè.
  • hemagglutination
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)
  • hemagglutination
    Ç÷±¸ÀÀÁý
  • hemagglutination =HA
    ÀûÇ÷±¸ÀÀÁý(¹ÝÀÀ)(îåúìϹëêó¢Úãëë).
  • hemagglutination =HA
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)(ËøÌ´Ë´Ëô̤ËÑËô).
  • hemagglutination inhibition antibody
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦Ç×ü.
  • hemagglutination inhibition antibody
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦Ç×ü.
  • hemagglutination inhibition reaction
    ÀûÇ÷±¸ÀÀÁý¾ïÁ¦¹ÝÀÀ.
  • hemagglutination inhibition test
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý ÀúÁö½ÃÇè
  • hemagglutination inhibition test =HIT
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè.
  • hemagglutination test
    (Àû)Ç÷±¸ÀÀÁý½ÃÇè
  • hemagglutination test
    Ç÷±¸ÀÀÁý¹ý
  • hemagglutination test
    Ç÷±¸ÀÀÁý °Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sensitized hemagglutination
    °¨ÀÛ(Àû)Ç÷±¸ÀÀÁý(ÊïíÂîåúìϹëêó¢).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cell, sensitized
    °¨ÀÛ¼¼Æ÷
  • cell, sensitized red blood
    °¨ÀÛÀûÇ÷±¸
  • sensitized antigen
    °¨ÀÛÇ׿ø(ÊïíÂù÷ê«).
  • sensitized cell
    °¨ÀÛ¼¼Æ÷
  • sensitized corpuscle
    °¨ÀÛÀûÇ÷±¸(ÊïíÂîåúìϹ).
  • sensitized erythrocyte agglutination test
    °¨ÀÛÀûÇ÷±¸ÀÀÁý½ÃÇè(ÊïíÂîåúìϹ ëêó¢ãËúÐ).
  • sensitized lymphocyte
    °¨ÀÛ¸²ÇÁ±¸.
  • sensitized lymphocyte
    °¨ÀÛ¸²ÇÁ±¸(Êïí¡­Ï¹)
  • sensitized red blood cell
    °¨ÀÛÀûÇ÷±¸.
  • sensitized vaccine
    °¨ÀÛ¹é½Å.
  • hemagglutination
    Ç÷±¸ÀÀÁý
  • hemagglutination
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)
  • hemagglutination =HA
    (Àû)Ç÷±¸ÀÀÁý(¹ÝÀÀ)(ËøÌ´Ë´Ëô̤ËÑËô).
  • hemagglutination =HA
    ÀûÇ÷±¸ÀÀÁý(¹ÝÀÀ)(îåúìϹëêó¢Úãëë).
  • hemagglutination inhibition antibody
    (Àû)Ç÷±¸ÀÀÁý¾ïÁ¦Ç×ü.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • dye-sensitized photooxidation
    »ö¼Ò °¨¼ö¼º ±¤»êÈ­(ßäáÈÊïáôàõÎÃß«ûù)
  • hemagglutination
    "(Àû,îå)Ç÷±¸(úìϹ) ÀÀÁý(ëêó¢)"
  • hemagglutination inhibition
    "(Àû,îå)Ç÷±¸(úìϹ) ÀÀÁý ÀúÇØ(ëêó¢îÁúª)"
  • passive hemagglutination
    ¼öµ¿ Ç÷¾×ÀÀÁý(áôÔÑúìäûëêó¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hemagglutination inhibition test
    Ç÷±¸ÀÀÁý¾ïÁ¦½ÃÇè
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IHA idiopathic hyperaldosteronism; indirect hemagglutination; indirect hemagglutination antibody
HI antibody Hemagglutination Inhibiting antibody; Ç÷±¸ ÀÀÁý ¾ïÁ¦ Ç×ü
HI Method Hemagglutination Inhibiting Method; Ç÷±¸ ÀÀÁý ¾ïÁ¦¹ý
MHA-TP Micro-Hemagglutination Assay for antibodies to Treponema Pallidum
CCH C-cell hyperplasia; chronic chloride hemagglutination; chronic cholestatic hepatitis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
HIT Hemagglutination inhibition test
IAHA Immune adherence hemagglutination
IHA Indirect Hemagglutination assay
PHA Passive hemagglutination assays
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chromium-sensitized YAG crystal
    Å©·Ò °¨ÀÛ¼º YAG °áÁ¤
  • sensitized cell
    °¨ÀÛ Ç÷±¸
    ÀûÇ÷±¸¿¡ ´ëÇÑ Ç×ü¿Í ÀûÇ÷±¸¸¦ °áÇÕ½ÃŲ °Í.
  • sensitized red blood cell
    °¨ÀÛ ÀûÇ÷±¸
    °¡¿ë¼ºÀÇ ´Ù´çü ¶Ç´Â ´Ü¹é Ç׿øÀ» °áÇÕ½ÃŲ ÀûÇ÷±¸.
  • hemagglutination
    ÀûÇ÷±¸ ÀÀÁý ¹ÝÀÀ
    Ç×ü¿¡ ÀÇÇØ »ý±â´Â °æ¿ì¿Í ¾î¶² Á¾·ùÀÇ ¹ÙÀÌ·¯½º ÀÔÀÚ¿¡ ÀÇÇÑ °æ¿ì ȤÀº °íºÐÀÚ µ¦½ºÆ®¶õ °°Àº ¹°Áú¿¡ ÀÇÇÑ °æ¿ì µîÀÌ ÀÖ´Ù.
  • hemagglutination inhibition test
    ÀûÇ÷±¸ ÀÀÁý ¾ïÁ¦ ½ÃÇè
  • indirect hemagglutination
    °£Á¢ Ç÷±¸ ÀÀÁý ¹ÝÀÀ
    ¼öµ¿ÀûÀ¸·Î Ç¥¸é¿¡ ÈíÂø½ÃŰ°Å³ª ¼¼Æ÷¿¡ È­ÇÐÀûÀ¸·Î °áÇÕ½ÃŲ Ç׿ø°ú ƯÀÌÇ×ü »çÀÌÀÇ ¹ÝÀÀ¿¡ ÀÇÇÑ ÀûÇ÷±¸ÀÇ ÀÀÁý.
  • passive hemagglutination
    Çǵ¿¼º ÀûÇ÷±¸ ÀÀÁý
  • viral hemagglutination
    ¹ÙÀÌ·¯½º Ç÷±¸ ÀÀÁý¹ý
  • virus hemagglutination inhibitor
    ¹ÙÀÌ·¯½º ÀûÇ÷±¸ ÀÀÁý¹ÝÀÀ ¾ïÁ¦ ÀÎÀÚ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
hemagglutination <haematology> Agglutination of red blood cells, often used to test for the presence of antibodies directed against red cell surface antigens or carbohydrate binding proteins or viruses in a solution. Requires that the agglutinin has at least two binding sites.
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á